France is gearing up for a possible easing of COVID-19 lockdown restrictions from mid-April, as vaccines, to date, are proving effective at lowering infection rates. French government spokesman Gabriel Attal said on Wednesday that while the nation is still facing hard times, “For the first time in months, the return to more normal living conditions is in sight.” Attal said vaccinated groups (mainly the elderly) are witnessing falling infection rates, which, he said, is a sign that the country’s vaccination program is working and should be sped up. "It is neither a distant nor uncertain horizon - it is an horizon that is getting closer and closer. We hope maybe from mid-April, and we are preparing for it. "The president (Emmanuel Macron) asked us to submit proposals that could allow for a cautious re-opening of the country soon,” he said. Attal added that the goal of vaccinating the most fragile was to reduce hospitalizations and safeguard the nation’s health care system, which is key to easing restrictions. Earlier this week, Health Minister Olivier Veran said France will retain its current measures aimed at limiting the spread of COVID-19, including a nighttime curfew, as a bare minimum for the next four to six weeks. Other measures now in force include the closure of bars, restaurants, museums, sports and music venues. COVID-19 is the disease caused by the coronavirus.
The World Health Organization (WHO) yesterday gave two versions of the AstraZeneca/Oxford COVID-19 vaccine the green light to be used for emergency use, listing them on its Emergency Use Listing (EUL), paving the way for them to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India. WHO’s EUL assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX Facility vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines. “Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk, contributing to the COVAX Facility’s goal of equitable vaccine distribution,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products. ‘But we must keep up the pressure to meet the needs of priority populations everywhere and facilitate global access. To do that, we need two things – a scale-up of manufacturing capacity, and developers’ early submission of their vaccines for WHO review.” Pfizer/BioNTech’s vaccine was listed for emergency use by WHO on 31 December 2020.
Young people with COVID-19 who are obese are at greater risk of being hospitalised and experiencing more severe symptoms, new research has found. According to the study of 3,615 patients who had tested positive for COVID-19, while being overweight didn’t appear to have any negative impact on individuals aged 60+, it did in younger patients. Compared to those with a healthy Body Mass Index (BMI), which is less than 30, patients with BMIs of 30-34 were twice as likely to need hospitalisation and twice as likely to need acute care. Meanwhile, while younger COVID-19 patients with BMIs of 35 or higher were also found to be twice as likely to require hospitalisation, they were three times more likely to end up in the intensive care unit. One of the study co-authors, Jennifer Lighter, MD, a hospital epidemiologist in New York City, said the findings are significant, especially in the US where 42% of the population has a BMI over 30 and is considered obese. “Our hospital was one of the first to find the association between obesity and coronavirus, but I think it will soon become very common,” Lighter said. It is important for frontline health workers to understand how being obese potentially changes a patient’s clinical outlook and consider such patients as high-risk.
If there wasn’t already enough motivation for overweight men to shed some pounds, new research suggests losing weight could help lower the risk of advanced prostate cancer. Prostate cancer is the second most common cancer in men globally, with approximately 1.3 million new cases in 2018 alone. Fortunately, if discovered early enough, prostate cancer has a relatively low mortality rate, with 96% of patients surviving for 15 years or more following an early stage diagnosis. However, as with any cancer, prevention is better than cure, and survival rates for advanced prostate cancer are very poor. That’s why a new, large-scale analysis of 15 studies involving nearly 831,000 men is significant. It found that having a Body Mass Index (BMI) of above 25 during middle to late adulthood was associated with the highest risk for advanced prostate cancer. Furthermore, the researchers from the Mailman School of Public Health at Columbia University found that having a larger waist size was also associated with an increased risk of advanced prostate cancer and death. “These study results show that risk for advanced prostate cancer can be decreased by maintaining a 'healthy' weight, which is in line with guidelines by the American Cancer Society and World Cancer Research Fund,” said study author Jeanine Genkinger, an associate professor of epidemiology at the Mailman School of Public Health The study was published March 4 in the Annals of Oncology.
Researchers have found fat in overweight and obese people’s lungs. It’s the first time such a discovery has been made and could provide important clues as to why overweight and obese people have an increased risk of asthma. For the research, a team from Australia analysed lung samples from 52 deceased individuals. They found the amount of fat present increased in line with Body Mass Index (BMI). Being overweight/obese is already linked to having asthma, but it was previously thought that excess weight pressing on the lungs was the main reason for this. However, the Australian researchers say fatty tissue in the walls of airways takes up space and causes inflammation, which can lead to wheezing and asthma. Speaking about the findings of the research, which are published in the European Respiratory Journal, Dr Peter Noble from the University of Western Australia said: “We’ve found that excess fat accumulates in the airway walls where it takes up space and seems to increase inflammation within the lungs. “We think this is causing a thickening of the airways that limits the flow of air in and out of the lungs, and that could at least partly explain an increase in asthma symptoms.” Experts say that more research is now needed to find out whether the build-up of fatty tissue could be reversed through weight loss. In the meantime, asthma patients should be supported to achieve a healthy weight.
Postmenopausal women who have more fat on their legs and thighs have less risk of stroke or heart disease than their peers who carry fat around their stomach, a new study has found. As a result of the research, the findings of which appear in the European Heart Journal, scientists say women should aim to be more “pear-shaped” than “apple-shaped”. For the research, scientists followed 2,600 women with BMIs of between 187 and 25 for 18 years. The scientists found that the women who were apple-shaped i.e. had fat around their stomachs were more than three times more likely to develop cardiovascular disease than the women who were pear-shaped i.e. had fat on their legs and thighs. It’s already known that fat stored in the visceral region (around the abdominal organs) can increase a person’s chances of developing type-2 diabetes and cardiovascular problems, but the exact reasons why remain unknown. Further research is needed. The advice for women (and men) is to reduce the amount of fat they have stored around their stomachs. Speaking about the findings of the study, Dr Sonya Babu-Narayan, associate medical director at the British Heart Foundation, said: “This study uncovers an interesting link between where fat is stored and your risk of heart attack and stroke, but can't tell us why it exists. “Future research to uncover how the distribution of body fat is related to these diseases could reveal important new ways to prevent and treat the world's biggest killer.”
A major study has found that the UK has a big obesity problem, and that there are severe health implications for people who are even just a little overweight. According to the research, which was funded by healthcare firm Novo Nordisk, individuals with a Body Mass Index (BMI) of 30-35 were 70% more likely to develop heart failure than their healthy weight peers (18.5-25 BMI). Furthermore, the study of 2.8 million adults also showed that people who were even slightly overweight were twice as likely to develop Type 2 diabetes. The study, which is due to be presented at the European Congress on Obesity (ECO) in Glasgow, also revealed: The risk of Type 2 diabetes for people with a BMI of 35-40 was almost nine times higher People with severe obesity (BMI of 40-45) were 12 times more likely to develop Type 2 diabetes People with severe obesity also had triple the risk of heart failure, high blood pressure, and dyslipidaemia (elevated levels of total or low-density lipoprotein (LDL) cholesterol levels, or low levels of high-density lipoprotein (HDL) cholesterol) A BMI of 40-45 was also linked with a 50% higher risk of dying prematurely from any cause Speaking about the findings of the study, Public Health England said “sustained action” was needed to tackle obesity.
As obesity rates across the world continue to rise, understanding exactly why we put on weight has never been more important. That’s why the findings of a new study, which looked at whether there is an association between when we eat and how much weight we gain, could be very significant. Presenting their findings at the ENDO 2019 conference, which took place in New Orleans, the scientists from the University of Colorado in Denver said there is a link between eating later in the day and having a higher BMI, as well as more body fat. For the study, 31 adults who were either overweight or obese and had an average age of 36 years were closely monitored to assess their sleep, levels of activity, and diet. Interestingly, the study also showed that the participants who ate later in the day still had an average of 7 hours sleep each night, suggesting that lack of sleep may not promote obesity after all. Speaking about the findings of the study, Dr. Adnin Zaman, lead author, said “These findings support our overall study, which will look at whether restricting the eating window to earlier on in the day will lower obesity risk.”
How many push-ups (also known as press-ups) can you do? Do you even know? Do you even care? Well maybe you should… That’s because a new study has found that a man’s ability to do push-ups may be a good indicator of their cardiovascular risk. The findings of the study by the Harvard T.H. Chan School of Public Health in Boston, MA, may enable physicians to assess cardiovascular risk more easily and more cost effectively. Simply put, the more push-ups a man can do, the lower his cardiovascular risk and vice versa. Speaking about the findings of the study, first author Justin Yang, M.D. said: "Our findings provide evidence that push-up capacity could be an easy, no-cost method to help assess cardiovascular disease risk in almost any setting.” For the study, researchers measured both the push-up capacity and the submaximal treadmill exercise tolerance of each participant at the beginning. Yearly physical exams and medical questionnaires were then used to gather relevant data. The researchers found that participants who were able to complete over 40 push-ups to begin with had a 96% lower cardiovascular risk than those who could only complete 10 or fewer push-ups. It is still unknown whether the findings of the study also apply to women and men who are older, younger and/or less physically fit than the participants. That’s the study involved 1,104 active male fire fighters with a mean age of 39.6 and mean BMI of 28.7.
A new study, one of the largest of its kind, suggests being the wrong weight i.e. overweight or underweight cold knock four years off a person’s life expectancy. According to the study, the findings of which were published in the Lancet Diabetes and Endocrinology journal, from the age of 40, people towards the higher end of the healthy Body Mass Index (BMI) range (a healthy BMI ranges from 18.5 to 25) had the lowest risk of dying from disease, including cancer and heart disease. In contrast, individuals who had BMI scores of less than 18.5 or more than 30 had life expectancies that were 4.4 years and 3.85 years shorter respectively. BMI scores, which are calculated by dividing a person’s weight (in kilograms) by their height (in metres squared), are still considered by health professionals to be the simplest and most accurate way to work out if someone is overweight or underweight. For the population-based cohort study, researchers analysed anonymised data on 3.6 million adults from the U.K. Clinical Practice Research Datalink (CPRD). Dr Krishnan Bhaskaran, lead author of the study, said: “The most striking thing about our findings was how widely BMI was linked to different causes of death. BMI was associated with deaths from nearly all major causes.” He added that the research reinforces the importance of maintaining a healthy body weight. Perhaps the most interesting finding is that people who have low BMI scores are at as much risk, if not more, of reducing their life expectancies.
New research published in the Journal of the American Heart Association shows that waist-to-hip ratio is a better heart attack predictor than body mass index (BMI), with so-called “apple shape” women at greater risk than their male counterparts. According to the research from the George Institute for Global Health, waist-to-hip ratio is an 18% better heart attack predictor than BMI in women and 6% in men. However, the research also found that BMI was linked to heart disease risk in both sexes. For the research, the team from the George Institute in Oxford interviewed nearly 500,000 UK adults aged 40 to 69. They found women who had bigger waists relative to their hips are at more risk of heart attacks than men with similar body shapes. Speaking about the findings of the research, Ashleigh Doggett, senior cardiac nurse at the British Heart Foundation, said: "Considering the large amount of UK participants, this is a very interesting study which highlights that obesity remains a risk factor for heart attacks in both men and women. "Interestingly, it suggests that those of us who are 'apple' as opposed to 'pear' shape, especially women, may be at higher risk of a heart attack.” The researchers say their findings suggest the differences in the way men and women store fat may affect their risk of heart disease. While more research is needed, these findings do support the notion that being “apple shape” (having proportionally more fat around the abdomen) is more hazardous for your health than being “pear shape” (having proportionally more fat stored around the hips. The full findings of the research can be found in the Journal of the American Heart Association.
Overweight or obese women may not detect cancerous breast lumps until they are much larger and more difficult to treat, a Swedish study has found. Researchers from the Karolinksa Institute studied more than 2,000 women who developed breast cancer between 2001 and 2008, all of who had been receiving mammograms every 18 months to two years, as is standard in Sweden. They found that women with higher body mass indexes (BMIs) were more likely to have a larger tumour when detected than women who were slimmer. Lead author of the study, Fredrik Strand, said this was either because the tumours were harder to detect because overweight women have larger breasts or because their tumours grew faster. Women who are overweight are already at greater risk of developing breast cancer and, unfortunately, larger tumours carry a worse prognosis. Therefore, these women may need more frequent mammograms to help spot tumours early, say the researchers. Women who are judged to be at greater risk of developing breast cancer – such as those with a family history – are already offered more frequent screening. Speaking about the findings of the study, Strand said: “Our study suggests that when a clinician presents the pros and cons of breast cancer screening to the patient, having high BMI should be an important 'pro' argument”.
A new report by Imperial College London in the United Kingdom, in collaboration with the World Health Organization (WHO), reveals that obesity in children is 10 times higher today than it was in 1975. Even more startling is the report’s prediction that within five years, more children will be obese than underweight. For the research, lead author Prof. Majid Ezzati, of the School of Public Health at ICL, and his team of over 1,000 researchers examined the body mass index (BMI) of almost 130 million people living in 200 countries, including 31.5 million individuals between 5 and 19 years old – making this study the largest of its kind. They found that total childhood obesity rates have risen globally by more than 10-fold in the past forty years. More specifically, in 1975, there were 5 million obese girls. In 2016, this number had risen to 50 million. A similar trend was found for boys, with 6 million obese in 1975 compared to 74 million in 2016. The researchers say that if the trend continues, there will be more obese children in the world than underweight ones by the end of 2020. Commenting on the findings, Prof. Ezzati said: “The trend predicts a generation of children and adolescents growing up obese and also malnourished. We need ways to make healthy, nutritious food more available at home and school, especially in poor families and communities, and regulations and taxes to protect children from unhealthy foods.” The findings of the study were published in The Lancet.
Men with waists over 40 inches and women with waists over 35 inches are at greater risk of certain cancers, as well as type 2 diabetes. That’s the message to come out of a study by scientists at the International Agency for Research on Cancer (IARC), which is an arm of the World Health Organisation. According to Dr Heinz Freisling, the lead author of the study published in the British Journal of Cancer, a person’s waist measurement is as good at predicting cancer risk as their body mass index (BMI). His advice is for people to know their waistlines. “You only need to put a tape measure around your belly button. This is easy to do and can give a person an indication of whether their risk for specific cancers is increased or not – for instance pancreas or liver cancer which are known to be related to increased body fatness or obesity,” he said. Being overweight or obese is the single biggest preventable cause of cancer after smoking and is linked to 13 types of cancer, including bowel, breast and pancreas. The study combined data from about 43,000 participants who had been followed for an average of 12 years and more than 1,600 people were diagnosed with an obesity-related cancer.
Despite the fact the number of people who are overweight or obese has risen over the past 30 years, fewer people are actually attempting to shed weight, according to a new study, the findings of which were published in JAMA. Around two thirds of the adult population in the United States are obese or overweight, putting them at increased risk of heart disease, stroke, diabetes, and other chronic diseases. However, new research has found that even though there has been a significant rise in the number of people who are overweight or obese since the 1980s, the percentage of U.S. adults who are trying to lose weight has fallen. For their research, study co-author Dr. Jian Zhang and her colleagues from the Georgia Southern University, analysed the data of 27,350 U.S. adults aged between 20 and 59 years. The analyses revealed that the rates of overweight and obesity increased by 13%, from 53% in 1988-1994 to 66% in 2009-2014. Furthermore, the researchers also found that the percentage of people who attempted to lose weight over the same period actually dropped by 7%, from 56% in 1988-1994 to 49% in 2009-2014. At present, people are deemed to be overweight or obese depending on their body mass index (BMI). A BMI of 25 to under 30 is considered overweight, while a BMI of 30 or above is considered obese. A healthy diet and regular physical activity are proven to help curb weight gain, which is why we should all make a conscientious effort to watch what we eat and exercise more. [Recommended read: BMI Wrongly Labelling People Unhealthy, Finds New Research]
Half of people labelled 'obese' because of their body mass index (BMI) scores are actually healthy, according to new research, bringing into question the validity of the scoring system. Scientists claim the BMI scoring system is wrongly labelling millions of people 'unhealthy' when, in fact, they are actually much healthier than their slimmer counterparts. Dr. A. Janet Tomiyama, an assistant professor in the department of Psychology at the University of California, Los Angeles, said: "Many people see obesity as a death sentence. But the data shows there are tens of millions of people who are overweight and obese and are perfectly healthy." Scientists say that BMI is being used by healthcare companies to increase premiums in some countries and that the latest findings will be "the final nail in the coffin for BMI." The problem with BMI is that it can give people false hope. For example, a person can have a 'normal' BMI, yet be at risk of disease, highlighting that it is not always an accurate predictor of future health. Prof Tomiyama and her colleagues discovered that more than 54 million Americans are being labelled as "unhealthy," even though they are not. The study - the results of which were published in the International Journal of Obesity - analysed the link between BMI and several health indicators, including blood pressure and glucose, and cholesterol and triglyceride levels. It found nearly half of Americans who are labelled 'overweight' because of their BMIs (34.4 million people) are healthy, as are 19.8 million who are considered 'obese'.
A Canadian study has questioned how a pregnant mother's consumption of beverages containing sweeteners might affect the weight of their unborn child. According to the authors, the risk of a mother's unborn child being overweight could be increased among those mothers who consume sweeteners on a daily basis. Dr. Meghan Azad, of the University of Manitoba, Winnipeg, Canada), and her staff questioned more than 3,000 women to learn about their eating habits during pregnancy. In addition, the body mass index (BMI) of their children was also measured at the age of one. The researchers made two main findings: 1. 5.1% of the young children at the age of one were already overweight. 2. Mothers who consumed one or more artificially sweetened drinks each day during their pregnancies doubled the risk of their unborn children being overweight by the time they were one. In conclusion, the researchers admit that their work includes some limitations such as the mothers reporting their eating habits via questionnaire. They point out, however, that "to their knowledge, this is the first study to investigate the potential effect of consuming artificial sweeteners during pregnancy and infant weight gain." In January 2015, the National Agency for Food Safety (ANSES) was less convinced. According to them, "the available data do not make it possible to identify any benefit or conclude on the risk associated with the consumption of intense sweeteners during pregnancy, whether it is maternal health, obstetric parameters, or health of the newborn."
A leading bariatric surgeon in the UK has urged the government to offer gastric surgery to patients regardless of their weight. According to Professor Francesco Rubino, the Chair of Bariatric and Metabolic Surgery at Kings College, thousands of type-2 diabetes patients in the UK are missing out on vital weight loss surgery because they do not meet the NHS's guidelines when it comes to weight. That's because, at present, only type-2 diabetes patients who have a BMI of over 30 are currently eligible for bariatric surgery. Rubino says that weight loss surgery is "the closest thing to a cure" and should be used more often. In the UK, there are around 3.6 million people with type-2 diabetes, which costs the NHS up to £10 billion a year to treat. However, approximately 15% of sufferers are "normal weight" and so don't qualify for weight loss surgery under the NHS's current guidelines. "The biggest barrier we have is primarily one of stigma against obesity. The vast majority of the public believes this is a cosmetic intervention and unfortunately many physicians think the same way," said Rubino. Rubino also highlighted that weight loss surgeries, which manipulate the stomach or small intestine, do not just help people lose weight, but actually influence insulin production by altering hormones in the person's gut. "More than 50% of people with type 2 diabetes can enjoy long term remission. Another 30 or 40% enjoy a major improvement," he added.
Babies whose mothers are obese or overweight are at risk of living considerably shorter lives, according to new research from Belgium. In fact, mothers who are overweight or obese risk shortening the lives of their babies by as much as 17 years. The researchers analysed information from 743 mothers aged between 17 and 44, and their newborn babies, using samples of blood from their umbilical cords immediately after delivery. Focusing on the length of the babies' telomeres, which are the caps on the end of chromosomes that protect them from damage, the researchers discovered a strong link between the Body Mass Index (BMI) of mothers and the length of their babies' telomeres. Specifically, they found that for every increase in the mother's BMI point above a normal level, the baby's telomeres were approximately 50 base pairs shorter. That's the equivalent of being 1.1 to 1.6 years older. The length of a person's telomeres is used as a good indicator of their biological age as they naturally shorten as people get older. The telomeres of babies whose mothers had a BMI of 40 suggested they were 17 years older biologically, placing them at higher risk of illness and premature death. In a statement accompanying the findings of the research, study co-author Tim Nawrot, a professor of environmental epidemiology at Hasselt University in Belgium, said: "Our results add to the growing body of evidence that high maternal BMI impacts fetal [DNA] programming, which could lead to altered fetal development and later life diseases."
The government of France is set to invest 670 million euros in setting up 12 bespoke centres for genome sequencing, which will help with the ongoing battle against cancer, diabetes and other rare illnesses. It follows the submission of a report to French Prime Minister Manuel Valls on Wednesday, in which health experts outlined recommendations for developing "personalised medicine". Recent developments in genome decoding have allowed suitable treatments to be developed for tumours that have resisted previous treatment attempts, and help patients benefit from cures for unusual diseases. Announcing the investment plans, French Health Minister Marisol Touraine said that some of the investment money will come from companies. When the first-ever DNA sequencing was started in 2003, it took over 10 years to complete at a cost of some three billion dollars. Nowadays, though, analyses of the most important of the genome can be completed in just a few days and cost as little as 1,000 euros. Experts say that DNA sequencing can uncover the disposition of individuals to certain complaints and provide insights into how they react to specific medications. The ultimate goal is to allow patients to find more suitable treatments more quickly. Google, Apple and Facebook are just some of the companies that have shown an interest in the sector, and China, the US and the UK have all already made similar investments.
SLEEVE GASTRECTOMY Sleeve Gastrectomy is a restrictive technique which consists of removing approximately two thirds of the stomach and, in particular, the part containing the cells that secrete the hormone that stimulates appetite (ghrelin). The stomach is reduced to a vertical tube and food passes quickly into the intestine. Appetite is also reduced. This technique does not interfere with the digestion process. Sleeve gastrectomy is sometimes the first step in a biliopancreatic diversion procedure. Expected Weight Loss: Around 45 to 65 % excess weight loss after 2 years, corresponding to a weight loss of approximately 25 to 35 kg. (studies with 2 years follow-up, for a person of average height (1.7 m) with a BMI of 40 kg/m) Mean operating time: 2 hours (Provided there are no complications during the operation). Mean length of hospital stay: 3 to 8 days (Provided there are no complications after the operation). Main complications risks : Ulcers, leakage or stenosis of the remnant stomach. Early postoperative bleeding. Possible nutritional deficiencies (to be monitored). Gastrooesophageal reflux (acids and foods coming back up the oesophagus) and inflammation of the oesophagus.Dilation of the stomach. French health facilities represented by France Surgery are all recognized Surgery Center of Excellence in European obesity surgery by the EAC-BS European Accreditation Council for Bariatric Surgery. CONSIDERING SLEEVE GASTRECTOMY IN FRANCE ? CLICK HERE FOR A FREE QUOTE To find out more about the advantages and disadvantages of the different Bariatric surgical techniques: http://www.laparoscopic-surgeon.com/ www.soffco.fr Société française et francophone de chirurgie de l’obésité www.mangerbouger.fr (French National Nutrition Health Programme) www.has-sante.fr (French Health Authority)
GASTRIC BYPASS SURGERY Gastric Bypass technique is used to reduce the stomach’s size and the food absorption in the digestive tube in order to trigger a significant weight loss. Often described as 'more comfortable' than Lap Band surgery by patients, this surgery is irreversible and implies a lifelong medical follow up and potential vitamins’ intake. The digestive bypass created during surgery leads to food derivation directly to the middle part of the small intestine. This surgery exists since 1990 and is performed on thousands of patients every year in France. We then have significant medical data to access its risk and benefits. GASTRIC BYPASS is conducted under general anaesthetic, usually via laparoscopy. This technique is recommended because it reduces the amount of pain experienced and allows the patient to return to normal activity quickly. In some cases, during the operation it is necessary to open up the abdomen (laparotomy) for safety reasons. The time spent in hospital will vary from 2 to 10 days depending on the type of operation and the general health of the patient. It may be extended. You should plan to have at least 2 weeks off work when you come out of hospital. Expected Weight Loss: Around 70 to 75 % excess weight loss, corresponding to a weight loss of approximately 35 to 40 kg (studies with 20 years follow-up for a person of average height 1.7 m with a BMI of 40 kg/m2). Mean operating time: 1,5 to 3 hours (Provided there are no complications during the operation). Mean length of hospital stay: 4 to 8 days (Provided there are no complications after the operation). Mean complications risk : Surgical complications: ulcers, leakage or stenosis at the junction between the stomach and the intestine, bleeding, occlusion of the intestine. Nutritional deficiencies. Functional complications: hypoglycaemia after meals, dumping syndrome, constipation French healthcare facilities represented by France Surgery are all recognized Surgery Center of Excellence in European obesity surgery by the EAC-BS European Accreditation Council for Bariatric Surgery. CONSIDERING GASTRIC-BYPASS IN FRANCE ? CLICK HERE FOR A FREE QUOTE To find out more about the advantages and disadvantages of the different Bariatric surgical techniques: http://www.laparoscopic-surgeon.com/ www.soffco.fr French Society for Bariatric surgery www.mangerbouger.fr (French National Nutrition Health Programme) www.has-sante.fr (French Health Autority)
A new study has suggested that obese or very overweight teenagers are at twice the risk of developing bowel cancer in later life than their slimmer peers. Bowel cancer is the fourth most common type of cancer in the UK and adult obesity has long been thought to increase the risk of contracting it. But now a team of researchers in the US have studied the records of some 240,000 men born in the early 1950s, who then went on to undergo a compulsory conscription assessment for the Swedish military in their late teens. The difference between being overweight and obese all depends on a person’s body mass index (BMI). Having a BMI of 30 or more sees someone labelled ‘obese’ but even over 25 is still considered ‘overweight’. All of the individuals were assessed in terms of their weight at the time of their conscription and while 81% were considered of ‘normal’ weight, 1.5% had a BMI of over 25 and 1% over 30. An analysis of their health 35 years later discovered that 885 had been positively diagnosed with bowel cancer. Scientists found that those in the uppermost weight bracket were 2.38 times more likely to develop the condition. While further research is needed, especially in women, the study by the Harvard School of Public Health in Boston, Massachusetts was published in the journal Gut and its authors said: "Even with these limitations it is important to recognise the unique strengths of this study.” Photo credit: CSIRO
Childhood obesity is a complicated disease that’s on the rise globally and now affects over twice as many children as it did 30 years ago. That’s according to the Centers for Disease Control and Prevention (CDC). In an attempt to understand how the link between parents and obese children can be used to improve paediatric health, researchers from the London School of Hygiene and Tropical Medicine studied the responses given by 2,976 questionnaire respondents – 369 of which had children who were heavily overweight. During the study, the researchers uncovered that 31 percent of the parents interviewed were unable to classify their own child’s BMI scale range. This is worrying because it suggests that many parents simply do not acknowledge when their child is overweight and, therefore, are unlikely to do anything about it. The study’s senior author, Dr. Sanjay Kinra - reader in clinical epidemiology at the London School of Hygiene and Tropical Medicine – said: "If parents are unable to accurately classify their own child's weight, they may not be willing or motivated to enact the changes to the child's environment that promote healthy weight maintenance.” Staggeringly, more than one third of American children are either overweight or obese and that’s a problem which will only worsen unless parents start taking measures now. Another of the study’s authors, Professor Russell Viner - an academic paediatrician at the UCL Institute of Child Health – said: "Measures that decrease the gap between parental perceptions of child weight status and obesity scales used by medical professionals may now be needed in order to help parents better understand the health risks associated with overweight and increase uptake of healthier lifestyles.” Photo credit: U.S. News
French President Francois Hollande had already given his backing for the city of Paris’s 2024 Olympic bid, but the city’s mayor had previously asked for more time to consider the proposal. But now, Anne Hidalgo has given her blessing following the submission of a report by French sports officials. It means that Paris is one step closer to declaring its official candidacy, but the French city’s council still need to vote on the final decision in April; ahead of the International Olympic Committee’s September deadline for submissions. A feasibility study put the cost of hosting the games in Paris at around 6.2 billion euros, but the bid’s backers have said that construction costs would be greatly reduced by the fact that the city already has the Stade de France and the Roland Garros tennis centre. Talking about her decision to back the bid, Hidalgo said: "These very useful exchanges confirmed it makes sense for Paris to bid for this unique sporting event.” Paris last hosted the Summer Olympics way back in 1924 and is still vying for another chance, having lost out to London in 2012. The news is great for the city of Paris and if successful, will serve to boost the French capital’s already booming tourism industry, which many of our patients have experienced during their time with us here at France Surgery.
As we get older, our bodies need a bit more TLC to ensure we’re fighting fit for the challenges that life throws at us. Therefore, when we reach the age of 40, there are certain medical tests which are recommended and specifically designed to check your vital systems. Also, these tests will inevitably be accompanied by a series of questions, so that a full picture of your health can be produced. Depending on the results, you may be given personalised advice by your medical professional and instructed to make lifestyle changes going forward. In some circumstances, you’ll be offered medical treatment to help maintain or improve your health. There are three simple tests that will help your medical professional determine your ‘heart age’. These are as follows: Cholesterol test We all need a certain amount of cholesterol for our bodies to function but there is strong evidence to suggest that too much cholesterol – particularly bad cholesterol – increases the risk of vascular diseases. A simple blood test is used to measure your cholesterol and you’ll know the result right away. Blood pressure test The higher your blood pressure the harder your heart has to work to pump blood around your body. This can not only weaken you heart but also increase your chances of developing a blocked artery. Your blood pressure is measured using a cuff that fits around your upper arm and is inflated. BMI test Your BMI or body mass index determines whether you are a healthy weight for your height. People with higher BMIs have a higher chance of developing certain conditions such as heart disease, certain cancers and stroke. Diabetes assessment In addition to the three tests above, a diabetes risk assessment is also recommended for people over 40. Diabetes occurs when your body does not produce enough insulin or when the insulin it does produce is not as effective as it should be. Your medical professional will ascertain through questions and the results of your blood pressure and BMI tests whether you are at risk of type 2 diabetes. A simple blood test will then confirm if your blood sugar is too high.
France Surgery is proud to offer a first class service for analysing test samples and providing results with the greatest of accuracy. We manage this from our ultra-modern laboratory in Southern France working with a highly skilled and experienced multi-disciplinary team medical professionals. Our medical office staff and capable logistics company handle the procedure of collecting, handling and managing sensitive medical packages within strict guidelines and with the highest level of proficiency, so as not to damage the accuracy of the results guaranteed by us. Depending on the analysis, results will be ready between one and five days from receiving the sample in our lab. These results will be submitted via our online secure platform, ensuring all data remains highly confidential and can be accessed only by the patient and consulting doctor. We understand our patients’ changing needs, so continually develop our services to provide trusted and beneficial healthcare to everyone. Contact us today for more information about France Lab.
And what about French quality standards : The entire healthcare system is regulated by government The majority of specialty activities are submitted to government authorisation, regarding equipment and qualification of medical teams such as for surgery, cancer treatment, interventional cardiology and many others. Regular assessment is operated by French Ministry of Health. The results of physicians practice, procedure numbers, morbidity ,complications are monitored and assessed. All facilities are certified every 3 years by the High Authority of Health – HAS with public access to findings and conclusions. Risk management and quality are a main preoccupation and the proof of this policy is mandatory in the certification process. One of the main concerns about Medical Travel is the control of Health Care associated infection. The French HAS publish annual results and statistics for every hospital in France, data is made public and may be viewed on the French HAS Web Site. All data is validated by European centre for disease prevention and control. Public and private hospitals are of course liability insured for International patients. All physicians need to register with the French Medical Council. Depending on their diplomas and degree course, the French Medical Council authorises the practice of a speciality within strict guidelines. The particular aspect of liability in private practice imply that French doctors have to be a graduate in France, otherwise they cannot obtain insurance against Malpractice. French medical graduation is one of the most famous and is very demanding. The level of training is very high, with at least six years for general medicine, five more years of residency to qualify as a medical specialist and at least 3 more years for a Surgeon. All professionals have a personal professional liability insurance with very high coverage standards. Subscription to this insurance is mandatory to join any hospital or medical team. An essential requirement is made to continuous medical education. France has a very ancient culture of CME to adapt practices to progress and to advance new technologies. So all physicians are really up to date in their technique and practice. State regulation and regional competition have led to very homogeneous standards all over the territory. The same quality of care may be found from Britain to Italian borders. Pluridisciplinary facilities are mainly very modern and fully equipped responding to the highest standards of certification.